Home / BDNEWS / bdnews24.com - Home / Vaccine from Sanofi and GSK said to produce strong immune responses in mid-stage study

Vaccine from Sanofi and GSK said to produce strong immune responses in mid-stage study

May 17, 2021 BDNEWS, bdnews24.com - Home

Sanofi, the French pharmaceutical company, said Monday that it would move the experimental COVID-19 vaccine it is developing with GlaxoSmithKline into a late-stage trial after the shot produced strong immune responses in volunteers in a mid-stage study.

from bdnews24.com - Home https://ift.tt/3eRgF6A

No comments

Subscribe to: Post Comments ( Atom )